US Patent Issued to Genentech on March 17 for "Method and medicament for treating cancer unresponsive to PD-1/PD-L1 signaling inhibitor" (Japanese Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,307, issued on March 17, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Method and medicament for treating cancer unresponsive to PD-1/PD-L1 signaling inhibitor" was invented by Nobuyuki Ishikura (Kanagawa, Japan), Toshiki Iwai (Kanagawa, Japan) and Masamichi Sugimoto (Kanagawa, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to medicaments, treatment methods, kits, and uses for treating cancer in individuals, characterized in that a VEGF signaling inhibitor and a PD-1/PD-L1 signaling inhibitor are administered in combination, as well as VEGF signaling inhibitors, PD-1/PD-L1 signaling inhibitors, a...